CytoSorbents Corp. (CTSO) - Total Stockholders' Equity

The current market quotes for Cytosorbents (CTSO) visualized below demonstrate the dynamics of the company developing blood purification systems. High barriers to entry are ensured by patents for polymer adsorbents and complex regulatory certifications. Professional management is successfully executing expansion in the US and European markets, where the indicator stands at -0.00. Regular sales of consumables guarantee a steady cash flow, confirming the relevance and sustainability of the business model.

When constructing a long-term portfolio, fundamental screening requires an assessment of the intrinsic value of assets to determine the business's margin of safety. This metric calculates the difference between total assets and liabilities, which, in the context of the large-scale robotization of cartridge production at Cytosorbents (CTSO), reflects capitalization into high-tech equipment and AI control systems, visualizing the real value of equity within the company's balance sheet capitalization.